Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
11.49
-0.52 (-4.33%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Cogent Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Revenue
----7.8722.5
Upgrade
Revenue Growth (YoY)
-----65.02%169.13%
Upgrade
Cost of Revenue
----25.7443.71
Upgrade
Gross Profit
-----17.87-21.21
Upgrade
Selling, General & Admin
38.7534.3826.2119.6417.4210.97
Upgrade
Research & Development
205.85173.76121.6355.91--
Upgrade
Operating Expenses
244.6208.13147.8475.5517.4210.97
Upgrade
Operating Income
-244.6-208.13-147.84-75.55-35.29-32.18
Upgrade
Interest & Investment Income
17.5213.083.990.470.140.27
Upgrade
Other Non Operating Income (Expenses)
0.042.643.212.81-0.25-
Upgrade
EBT Excluding Unusual Items
-227.05-192.41-140.64-72.27-35.39-31.91
Upgrade
Gain (Loss) on Sale of Assets
----7.490.08
Upgrade
Asset Writedown
--0.4---
Upgrade
Pretax Income
-227.05-192.41-140.24-72.27-74.81-31.83
Upgrade
Earnings From Continuing Operations
--192.41-140.24-72.27-74.81-31.83
Upgrade
Net Income
-227.05-192.41-140.24-72.27-74.81-31.83
Upgrade
Preferred Dividends & Other Adjustments
----104.4-
Upgrade
Net Income to Common
-227.05-192.41-140.24-72.27-179.21-31.83
Upgrade
Shares Outstanding (Basic)
92805939118
Upgrade
Shares Outstanding (Diluted)
92805939118
Upgrade
Shares Change (YoY)
28.40%35.61%51.66%249.52%45.42%-
Upgrade
EPS (Basic)
-2.47-2.42-2.39-1.87-16.17-4.18
Upgrade
EPS (Diluted)
-2.47-2.42-2.39-1.87-16.17-4.18
Upgrade
Free Cash Flow
-177.93-156.42-125.5-60.48-35.85-41.55
Upgrade
Free Cash Flow Per Share
-1.94-1.96-2.14-1.56-3.24-5.45
Upgrade
Gross Margin
-----227.00%-94.27%
Upgrade
Operating Margin
-----448.34%-143.02%
Upgrade
Profit Margin
-----2276.81%-141.49%
Upgrade
Free Cash Flow Margin
-----455.47%-184.66%
Upgrade
EBITDA
-242.22-205.86-147-75.4-34.57-30.89
Upgrade
EBITDA Margin
------137.27%
Upgrade
D&A For EBITDA
2.382.270.840.150.721.29
Upgrade
EBIT
-244.6-208.13-147.84-75.55-35.29-32.18
Upgrade
EBIT Margin
------143.02%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.